CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.220
-0.060 (-1.83%)
At close: Oct 9, 2026, 4:00 PM EDT
3.260
+0.040 (1.24%)
After-hours: Oct 9, 2026, 7:45 PM EDT
CervoMed Employees
CervoMed had 15 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes CervoMed the 39,069th largest employer in the world and 5,712th in the United States.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$22,086
Profits / Employee
-$2,023,316
Market Cap
48.68M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 0 | - |
| Dec 31, 2024 | 15 | 7 | 87.50% |
| Dec 31, 2023 | 8 | 4 | 100.00% |
| Mar 31, 2023 | 4 | - | - |
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Caribou Biosciences | 97 |
| Elicio Therapeutics | 33 |
| eXoZymes | 32 |
| INmune Bio | 21 |
| ImageneBio | 18 |
| Edesa Biotech | 17 |
| Serina Therapeutics | 16 |
CRVO News
- 11 days ago - CervoMed neflamapimod update removes key overhang, says Jones - TheFly
- 11 days ago - CervoMed announces PK results with new neflamapimod oral tablet formula - TheFly
- 11 days ago - CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit - GlobeNewsWire
- 17 days ago - CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 24 days ago - CervoMed Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - CervoMed Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026 - GlobeNewsWire
- 4 weeks ago - CervoMed to Participate in September Investor Conferences - GlobeNewsWire